Glyhill Trio 2mg/500mg/0.2mg Tablet SR
Marketer
Daffohils Laboratories Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glyhill Trio 2mg/500mg/0.2mg Tablet SR
Trioglyce 2mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy treats type 2 diabetes in adults by regulating blood glucose. Trioglyce should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary foods, fruit juice) is essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Primary Ingredients of Glyhill Trio 2mg/500mg/0.2mg Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Glyhill Trio 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glyhill Trio 2mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Glyhill Trio 2mg/500mg/0.2mg SR Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Glyhill Trio 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glyhill Trio 2mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glyhill Trio 2mg/500mg/0.2mg Tablet SR. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Administer on an empty stomach.
How Glyhill Trio 2mg/500mg/0.2mg Tablet SR works:
Glyhill Trio extended-release tablets (2mg/500mg/0.2mg) contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glyhill Trio 2mg/500mg/0.2mg SR tablets is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glyhill Trio 2mg/500mg/0.2mg Tablet SR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The sustained-release Glyhill Trio tablet (2mg/500mg/0.2mg) is likely unsuitable for use while breastfeeding. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with abnormally low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Glyhill Trio 2mg/500mg/0.2mg SR tablets pose a likely risk for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is unsuitable for patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glyhill Trio 2mg/500mg/0.2mg SR tablets cautiously, as dose modification may be necessary. Individuals with mild to moderate liver disease should typically begin with a reduced Glyhill Trio 2mg/500mg/0.2mg SR tablet dosage; however, its use is contraindicated in those with severe liver dysfunction. Medical advice is recommended.
What if you forget to take Glyhill Trio 2mg/500mg/0.2mg Tablet SR :
Should you forget to take a Glyhill Trio 2mg/500mg/0.2mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glyhill Trio 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently